Researchers found that an at-home self-collection device for HPV testing demonstrated high accuracy and safety, matching clinician-collected results for cervical cancer screening.
A 5-year national study of over 8,800 cases found that fewer than 40% of patients with gonorrhea and just 14% of those with chlamydia were treated with CDC-recommended antibiotics in U.S. primary care.
April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.
A recent study reveals that 80% of women with STIs may have bacterial vaginosis, highlighting the potential benefits of simultaneous STI and vaginitis testing in clinical practice.